RecruitingNCT01694953

The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

The Rare Disease Clinical Research Network Natural History Study of MNGIE


Sponsor

Columbia University

Enrollment

20 participants

Start Date

Feb 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.


Eligibility

Min Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This natural history study follows patients with MNGIE (Mitochondrial NeuroGastroIntestinal Encephalopathy) — a very rare inherited disease that affects the gut, nervous system, muscles, and eyes — to understand how the disease progresses over time and identify potential treatment targets. You may be eligible if: - You are at least 5 years of age - You have a confirmed MNGIE diagnosis: deficient thymidine phosphorylase (TP) enzyme activity or mutations in the TYMP gene, AND elevated plasma thymidine and deoxyuridine levels You may NOT be eligible if: - You are currently participating in another interventional study - You are unable to travel to the study site - You are unwilling to sign informed consent - You have a substance abuse problem Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Columbia University

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01694953